ANNE VANLENT
CIK 1229243 · Exec VP & CFO · last filed 2026-06-04
ANNE VANLENT is an Exec VP & CFO who has filed 59 SEC Form 4 insider transactions across 12 companies since 2007. The most recent filing, for TRVI, was dated Jun 4, 2026. Across all open-market trades the lifetime net is −$130.4K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $448.8K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$448.8K
12
59
-$130.4K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| TRVI | Director | 20,983 | $14.21 | $298.2K | $50.0K | 10 | 2026-06-04 |
| APPLIED GENETIC TECHNOLOGIES CORP (AGTC) Delisted | Director | — | $0.39 | — | $0 | 9 | 2022-12-01 |
| Vaxart, Inc. (VXRT) Delisted | Director | — | $0.32 | — | $0 | 1 | 2019-06-14 |
| AVIR | Director | — | $4.49 | — | $0 | 2 | 2017-05-22 |
| NOVELION THERAPEUTICS INC. (NVLN) Delisted | Director | — | — | — | $0 | 1 | 2016-12-27 |
| Aegerion Pharmaceuticals, Inc. (AEGR) Delisted | Director | 0 | — | — | $0 | 3 | 2016-11-30 |
| Vaxart, Inc. (BOTA) Delisted | Director | 35,000 | — | — | $76.9K | 4 | 2015-08-13 |
| Traws Pharma, Inc. (ONTX) Delisted | Director | — | $1.00 | — | $0 | 3 | 2015-06-17 |
| Ocera Therapeutics, Inc. (TZYM) Delisted | Director | — | — | — | $0 | 2 | 2012-08-09 |
| IART | Director | 8,478 | $17.77 | $150.7K | -$250.3K | 8 | 2012-05-21 |
| PENWEST PHARMACEUTICALS CO (PPCO) Delisted | Director | 0 | — | — | -$7.0K | 8 | 2010-09-22 |
| BARRIER THERAPEUTICS INC (BTRX) Delisted | Exec VP & CFO | 148,852 | — | — | $0 | 2 | 2008-03-17 |
Recent Filings
59 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-04 | TRVI | Grant (A) | — | $0 | EDGAR |
| 2025-06-13 | TRVI | Grant (A) | — | $0 | EDGAR |
| 2024-06-14 | TRVI | Grant (A) | — | $0 | EDGAR |
| 2023-06-30 | TRVI | Grant (A) | — | $0 | EDGAR |
| 2022-12-01 | APPLIED GENETIC TECHNOLOGIES CORP (AGTC) Delisted | Disp (D) | — | $0 | EDGAR |
| 2022-07-01 | TRVI | Grant (A) | — | $0 | EDGAR |
| 2022-06-23 | TRVI | Grant (A) | — | $0 | EDGAR |
| 2021-12-02 | APPLIED GENETIC TECHNOLOGIES CORP (AGTC) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-06-17 | TRVI | Grant (A) | — | $0 | EDGAR |
| 2020-12-18 | APPLIED GENETIC TECHNOLOGIES CORP (AGTC) Delisted | Grant (A) | — | $0 | EDGAR |